Ownership history in M. Kraus & Co · 49 quarters on record
This page tracks every 13F SEC filing in which M. Kraus & Co reported a position in AbbVie Inc. (ABBV). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 39,248 | — | 0% | 2.50% | $9.0M | $226.67 |
| 2025 Q3 | REDUCED | 39,248 | -675 | -1.7% | 2.54% | $9.1M | $228.05 |
| 2025 Q2 | ADDED | 39,923 | +234 | +0.6% | 2.18% | $7.4M | $181.25 |
| 2025 Q1 | REDUCED | 39,689 | -825 | -2.0% | 2.53% | $8.3M | $202.72 |
| 2024 Q4 | ADDED | 40,514 | +371 | +0.9% | 2.16% | $7.2M | $170.33 |
| 2024 Q3 | REDUCED | 40,143 | -1,175 | -2.8% | 2.32% | $7.9M | $187.79 |
| 2024 Q2 | REDUCED | 41,318 | -130 | -0.3% | 2.17% | $7.1M | $161.62 |
| 2024 Q1 | ADDED | 41,448 | +1,165 | +2.9% | 2.29% | $7.5M | $170.00 |
| 2023 Q4 | ADDED | 40,283 | +2,363 | +6.2% | 2.03% | $6.2M | $143.30 |
| 2023 Q3 | REDUCED | 37,920 | -705 | -1.8% | 2.01% | $5.7M | $136.47 |
As of 2025 Q4 — sorted by position size